CAR-T Cells for the Treatment of Lung Cancer

CAR-T Cells for the Treatment of Lung Cancer

Adoptive cell therapy with genetically modified T lymphocytes that express chimeric antigen receptors (CAR-T) is one of the most promising advanced therapies for the treatment of cancer, with unprecedented outcomes in hematological malignancies. However, the efficacy of CAR-T cells in solid tumors i...

Full description

Bibliographic Details
Main Authors: Luisa Chocarro, Hugo Arasanz, Leticia Fernández-Rubio, Ester Blanco, Miriam Echaide, Ana Bocanegra, Lucía Teijeira, Maider Garnica, Idoia Morilla, Maite Martínez-Aguillo, Sergio Piñeiro-Hermida, Pablo Ramos, Juan José Lasarte, Ruth Vera, Grazyna Kochan, David Escors
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Life
Subjects:
CAR-T
adoptive cell therapy
immunotherapy
solid tumors
lung cancer
Online Access:https://www.mdpi.com/2075-1729/12/4/561

Internet

https://www.mdpi.com/2075-1729/12/4/561

Similar Items